Global Mesalazine Market Research Report 2021

Global Mesalazine Market Research Report 2021

  • QYResearch
  • February 2021
  • Pharmaceutical
  • 117 pages

Report Description

1
1
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Purity 97 %
Purity 98 %
Purity 99 %
According to the type, purity 98% is the highest, reaching 48.44% in 2019.

Segment by Application
Mesalazine Tablets
Mesalazine Capsules
Others
Mesalazine tablets has the highest market share in terms of application, at 50.61% in 2019.

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Syntese A/S
Divis Laboratories
Cambrex Corporation
Ipca Laboratories
PharmaZell
Lasa Loboratory
Erregierre SpA
Corden Pharma Bergamo
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Xinxiang Tianfeng Fine Chemical

Have query on this report?

Make an Enquiry
1 Mesalazine Market Overview
1.1 Product Overview and Scope of Mesalazine
1.2 Mesalazine Segment by Type
1.2.1 Global Mesalazine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Purity 97 %
List of Tables
Table 1. Global Mesalazine Sales (Ton) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Mesalazine Sales (Ton) Comparison by Application (2021-2027)
Table 3. Global Mesalazine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Mesalazine Covered in This Study
Table 5. Global Mesalazine Sales (Ton) of Key Manufacturers (2016-2021)

Success Stories

Our Clients